Clinical Trial Update: A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BMS986365 in combination with degarelix for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BMS986365
• degarelix (degarelix)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING